Private insurers often refer to the compendia and make similar reimbursement decisions. Here, off-label refers to prescription of pharmaceuticals for an unapproved indication, age group, dose, or ...

Compendia Bioscience received a $2.4 million SBIR Fast Track Award to improve upon its online cancer gene expression analysis tool, Oncomine.

They found inconsistencies: Different compendia listed Tarceva for off-label use for different forms of cancer. The researchers also found weak evidence supporting the off-label listings.

Compendia — which was formed from Platinum Entertainment assets in the wake of that company’s 2000 Chapter 11 filing — is expected to have net sales of $9 million-$10 million this year.

Compendia Bioscience will analyze the data generated by the assay and will perform correlation studies to end-points of interest — such as drug response. This will allow for development of multiple ...

Platinum successor turns up activity after a year regrouping By Joe Morris – Nashville Business Journal Apr 21, 2002UpdatedApr 21, 2002, 11:00pm CDT ...

"Compendia has become an integral part of the pharmaceutical industry's cancer drug discovery programs, and in joining Life Technologies, we'll gain the opportunity to expand the utility of Compendia ...

Compendia president/CEO Michael Olsen, who describes the cuts as “a painful and unfortunate part of the job,” says those “back-office functions” will be consolidated in Sheridan Square’s ...

The two compendia that Medicare Part D recognizes to make coverage determinations for off-label prescribing were “incomplete, outdated, idiosyncratic, and unpredictable” for some ...

Life Tech chief executive Gregory Lucier said by combining the recent acquisitions of Pinpoint Genomics and Navigenics, plus Compendia, “we now possess the full spectrum capability to develop and ...